VDR rs11568819: Understanding Your Promoter Variant
The rs11568819 single-nucleotide polymorphism is a regulatory variation found in the promoter region of the human vitamin D receptor (VDR) gene. It alters a specific binding site for the intestine-specific transcription factor Cdx-2, influencing VDR expression levels in intestinal tissues. Published research links this variant to modest shifts in intestinal calcium absorption and bone mineral density, though current scientific evidence remains limited and context-dependent.
What each genotype means
Typical VDR promoter activity
This genotype represents the common variant in the VDR gene promoter, often referred to in literature as the Cdx-2 binding site polymorphism. Research into this site suggests it may influence how the vitamin D receptor gene is expressed, though associations with bone mineral density and calcium absorption remain inconsistent across different studies. This is considered a common genetic variation rather than a disease-causing mutation.
This genotype is common in many populations, though its frequency varies significantly by ancestry, being more prevalent in European populations compared to East Asian populations.
Typical VDR promoter activity
Carrying one copy of each allele at this VDR promoter site is a frequent observation in diverse populations. While this site is a known regulatory region for the vitamin D receptor, current scientific evidence does not establish this specific genotype as a primary driver of clinical health outcomes. It is generally viewed as a normal variation in human genetic diversity.
This heterozygous genotype is frequently observed and is often the most common genotype found in many studied cohorts.
Typical VDR promoter activity
This genotype corresponds to the alternative allele at the VDR promoter Cdx-2 binding site. While some research has explored whether this variation alters vitamin D receptor expression or bone health, findings have been mixed and are not considered definitive for clinical prediction. It is a common genetic variant and is not diagnostic of any specific health condition.
This genotype is found at varying frequencies globally, with higher prevalence noted in East Asian populations compared to European populations.
Genetic Location and Molecular Function
The single-nucleotide polymorphism rs11568819 is situated in the 5-prime upstream promoter regulatory domain of the vitamin D receptor (VDR) gene on chromosome 12 according to [NCBI dbSNP](https://www.ncbi.nlm.nih.gov/snp/rs11568819). Specifically, this variant alters an interaction motif recognized by caudal-related homeobox-2 (Cdx-2), a transcription factor expressed predominantly in intestinal epithelial cells. When Cdx-2 binds to this sequence, it stimulates transcriptional activity, driving the expression of VDR in the gut. The common reference allele (often designated G) provides baseline transcription efficiency, while the alternative allele (often designated A) has been observed in functional assays to enhance transcription factor binding affinity. This functional difference leads to altered promoter activity and varying levels of intestinal vitamin D receptor abundance between genotypes.
The Biological Role of the VDR Gene
The VDR gene encodes the vitamin D receptor, a member of the nuclear steroid hormone receptor superfamily as detailed by [MedlinePlus Genetics](https://medlineplus.gov/genetics/gene/vdr). When activated by calcitriol—the bioactive hormonal form of vitamin D (1,25-dihydroxyvitamin D3)—the VDR protein forms a heterodimer complex with retinoid X receptor (RXR). This complex binds to specific vitamin D response elements across the genome to initiate transcription of genes that control intestinal absorption of dietary calcium and phosphate. Through this primary pathway, VDR helps maintain tight systemic mineral homeostasis, structural bone remodeling, and healthy skeletal integrity, while also playing secondary roles in cellular differentiation and immune signaling.
Associated Health Predispositions and Scientific Evidence
Epidemiological studies and candidate-gene research have evaluated rs11568819 primarily for its role in bone mineral density (BMD), fracture risk, and intestinal calcium uptake as cataloged in [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=rs11568819). Because the A allele has been shown to increase intestinal VDR transcriptional efficiency, some studies associate it with enhanced calcium absorption and relatively favorable bone density markers. Conversely, the more common G allele has occasionally been linked to lower baseline bone density measurements or higher fracture incidence in select cohorts. Nevertheless, evidence supporting these effects is classified as limited. Broad genome-wide association studies (GWAS) often show modest or non-replicable effect sizes, and outcomes vary considerably depending on dietary calcium intake and systemic vitamin D levels.
Understanding Limitations and Practical Action
It is essential to understand that rs11568819 is a predisposition marker, not a causal or diagnostic mutation according to entries in [ClinVar](https://www.ncbi.nlm.nih.gov/clinvar/?term=rs11568819). Having one or two copies of a particular allele does not predict bone fractures, osteoporosis, or calcium malabsorption on its own. Skeletal health is a complex trait governed by hundreds of genetic loci, physical activity, dietary calcium, hormone levels, and overall vitamin D sufficiency. Individuals should never adjust nutritional supplementation or prescription therapies based solely on consumer genetic results. Any concerns regarding bone mineral density, fracture risk, or vitamin D status should be evaluated clinically through validated tests—such as serum 25-hydroxyvitamin D screening or bone densitometry (DEXA)—under the guidance of a qualified healthcare provider.
How common is this variant?
The minor A allele frequency ranges between approximately 0.15 and 0.20 in European ancestry populations, rises to around 0.45 in East Asian populations, and reaches up to 0.74 in African cohorts.
Frequently asked questions
What does the VDR rs11568819 variant mean for my health?
This variant lies within the control region of the vitamin D receptor gene and subtly influences how efficiently intestinal cells produce the receptor. While some studies suggest it may modulate calcium absorption and bone density, its practical effect on overall health is small. It represents a mild predisposition rather than a direct cause of bone weakness.
Does having the GG genotype mean I will develop osteoporosis?
No, having the GG genotype does not mean you will develop osteoporosis or experience bone fractures. Many other genetic and lifestyle factors—such as weight-bearing exercise, hormonal health, and balanced nutrition—play far larger roles in bone strength. The GG genotype simply represents the common baseline promoter configuration.
Should I take extra calcium or vitamin D supplements if I have this variant?
You should not alter your dietary supplement intake based solely on your rs11568819 genotype. Supplementation decisions are best made by evaluating measurable blood markers, such as serum 25-hydroxyvitamin D, in consultation with a physician or registered dietitian. Excessive supplementation without medical supervision can carry health risks.
Why do different studies show conflicting results for this variant?
The relationship between rs11568819 and bone health is easily modified by environmental factors, including daily dietary calcium intake and sun exposure. In populations with abundant calcium in their diets, subtle differences in receptor expression may produce no measurable clinical effect. Variations in study design and ancestral background also contribute to mixed findings across research literature.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11568819?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VDR
Variant in the promoter region (Cdx2 site) of the vitamin D receptor gene associated with altered intestinal calcium absorption and bone mineral density.
This variant in the Vitamin D receptor gene is associated with susceptibility to Type 1 Diabetes and autoimmune thyroid disease.
Promoter polymorphism (Cdx2) in the VDR gene associated with bone mineral density and vitamin D metabolism.
Common polymorphism (TaqI variant) in the vitamin D receptor affecting mRNA stability and bone mineral density.
Known as the TaqI polymorphism, this variant is located in the 3' UTR of the VDR gene and is associated with altered mRNA stability, influencing vitamin D signaling, cancer cachexia susceptibility, and gastric cancer risk.
The Cdx2 polymorphism in the VDR promoter influences vitamin D receptor expression and is associated with bone mineral density.